Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase II Study of Pazopanib to Enable Partial Nephrectomy

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01158521
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:37:09.153040+00:00
Published At
2018-09-12T00:00:00+00:00
Record Updated At
2018-09-12
Results Posted At
2018-09-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Clear Cell Renal Cell Carcinoma", "Stage I Renal Cell Cancer", "Stage II Renal Cell Cancer", "Stage III Renal Cell Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2018-09-12"
protocolSection.identificationModule.nctId
"NCT01158521"
protocolSection.identificationModule.officialTitle
"A Phase II Study of Pazopanib to Enable Partial Nephrectomy"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2018-09-12"

Study condition terms

  • Clear Cell Renal Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Stage II Renal Cell Cancer (protocolSection.conditionsModule.conditions)
  • Stage III Renal Cell Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.